Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference

Castle Biosciences (Nasdaq:CSTL) announced that executive management will present a company overview at the 2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026, at 1:20 p.m. ET.

Rhea-AI Summary

Castle Biosciences (Nasdaq:CSTL) announced that executive management will present a company overview at the 2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026, at 1:20 p.m. ET. A live audio webcast and replay will be accessible via the company’s website.

Argus May 13 session

-2.58% close to close Open Argus

Details

News Market Reaction – CSTL

On May 13, the day this news came out, CSTL closed 2.58% below the previous close.

Data tracked by StockTitan Argus for the May 13 session.

Market Context

This announcement highlights Castle Biosciences’ participation in the 2026 Jefferies Global Healthca...

Analysis

This announcement highlights Castle Biosciences’ participation in the 2026 Jefferies Global Healthcare Conference on June 3, offering management another platform to present its story. It follows Q1 2026 results with $83.7M revenue and raised 2026 guidance, as well as recent clinical and advocacy updates. Investors may focus on how conference commentary reinforces prior guidance, test growth trends, and the strategic role of dermatology and gastroenterology diagnostics.

Key Figures

Conference date: June 3, 2026 Presentation time: 1:20 p.m. Eastern

Conference date

June 3, 2026

Jefferies Global Healthcare Conference presentation date

Presentation time

1:20 p.m. Eastern

Scheduled company overview session at Jefferies conference

Historical Context

5 past events · Latest: May 06

5 events

1. May 06

   Q1 2026 earnings

   24h Move

   -22.3%

   Reported Q1 2026 results and raised full-year revenue guidance range.

2. May 05

   Advocacy initiatives

   24h Move

   -3.6%

   Supported nationwide advocacy, screenings and education for Skin Cancer Awareness Month.

3. May 04

   Clinical data update

   24h Move

   +2.9%

   Presented Mayo Clinic data showing TissueCypher improves Barrett’s esophagus risk management.

4. Apr 21

   Upcoming data presentations

   24h Move

   -2.3%

   Announced DecisionDx-Melanoma data presentations at EADO and ACMS meetings.

5. Apr 15

   Earnings date notice

   24h Move

   +1.0%

   Scheduled Q1 2026 earnings release and webcast details for May 6.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FRIENDSWOOD, Texas, May 13, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the 2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026, at 1:20 p.m. Eastern time.

A live audio webcast of the Company's presentation will be available by visiting Castle Biosciences' website or at this link. A replay of the webcast will be available following the conclusion of the live broadcast.

About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. With a primary focus in dermatologic and gastroenterological disease, we develop personalized, clinically actionable solutions that help improve disease management and patient outcomes.

We put people first—empowering patients and clinicians and informing care decisions through rigorous science and advanced molecular tests that support more confident treatment planning. To learn more, visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.

DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, AdvanceAD-Tx, TissueCypher, Esopredict, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.

Investor Contact:
Camilla Zuckero
czuckero@castlebiosciences.com

Media Contact:
Allison Marshall
amarshall@castlebiosciences.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/castle-biosciences-to-present-at-the-2026-jefferies-global-healthcare-conference-302770056.html

SOURCE Castle Biosciences, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Castle Biosciences (CSTL) present at the 2026 Jefferies Global Healthcare Conference?

Castle Biosciences will present on Wednesday, June 3, 2026, at 1:20 p.m. Eastern time. According to Castle Biosciences, executive management will deliver a company overview as part of the 2026 Jefferies Global Healthcare Conference agenda.

How can investors listen to Castle Biosciences' 2026 Jefferies Conference presentation (CSTL)?

Investors can listen via a live audio webcast available on Castle Biosciences’ website. According to Castle Biosciences, the webcast link will be accessible from the company’s site and will stream the full conference presentation in real time.

Will a replay of Castle Biosciences' June 3, 2026 CSTL conference webcast be available?

Yes, a replay of the webcast will be available after the live broadcast concludes. According to Castle Biosciences, investors can access the replay through the same online location used for the original live audio webcast of the presentation.

What will Castle Biosciences (CSTL) cover in its 2026 Jefferies Global Healthcare Conference presentation?

Castle Biosciences plans to present an overview of the company during the conference session. According to Castle Biosciences, executive management will discuss the business using a structured company overview format as part of the scheduled presentation.

Where can I find the webcast link for Castle Biosciences' 2026 Jefferies conference presentation?

The webcast link will be available on Castle Biosciences’ website for investors to access. According to Castle Biosciences, the live audio webcast and subsequent replay can be reached by visiting the company’s online investor or events section.